PH31204A - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number
PH31204A
PH31204A PH43369A PH43369A PH31204A PH 31204 A PH31204 A PH 31204A PH 43369 A PH43369 A PH 43369A PH 43369 A PH43369 A PH 43369A PH 31204 A PH31204 A PH 31204A
Authority
PH
Philippines
Prior art keywords
pharmaceutical composition
chem
image
disclosed
organic solvent
Prior art date
Application number
PH43369A
Other languages
English (en)
Inventor
Sotoo Asakura
Yasuto Koyama
Michiyo Fukae
Shigeo Nakanishi
Youhei Kiyota
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PH31204A publication Critical patent/PH31204A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH43369A 1990-11-02 1991-10-29 Pharmaceutical composition. PH31204A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29813590 1990-11-02
JP29813690 1990-11-02

Publications (1)

Publication Number Publication Date
PH31204A true PH31204A (en) 1998-05-05

Family

ID=26561392

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43369A PH31204A (en) 1990-11-02 1991-10-29 Pharmaceutical composition.

Country Status (17)

Country Link
US (1) US5955469A (ja)
EP (1) EP0483842B1 (ja)
JP (1) JPH059117A (ja)
KR (1) KR100206722B1 (ja)
CN (1) CN1069194C (ja)
AT (1) ATE115400T1 (ja)
AU (1) AU655603B2 (ja)
CA (1) CA2054629C (ja)
DE (1) DE69105915T2 (ja)
DK (1) DK0483842T3 (ja)
ES (1) ES2064856T3 (ja)
HU (1) HU217540B (ja)
IE (1) IE66592B1 (ja)
PH (1) PH31204A (ja)
PT (1) PT99398B (ja)
RU (1) RU2084222C1 (ja)
UA (1) UA43820C2 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU696956B2 (en) * 1993-03-22 1998-09-24 Betatene Pty Ltd Water dispersible therapeutic compounds
JPH08510994A (ja) * 1993-03-22 1996-11-19 ベータティーン・リミテッド 黒色腫治療用薬剤
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4447972B4 (de) * 1993-05-27 2007-12-27 Novartis Ag Galenische Formulierungen
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
ATE214593T1 (de) * 1994-10-26 2002-04-15 Novartis Erfind Verwalt Gmbh Verwendung eines ungesättigten fettalkohols
WO1997010806A1 (en) 1995-09-19 1997-03-27 Fujisawa Pharmaceutical Co., Ltd. Aerosol compositions
USRE39072E1 (en) * 1997-04-04 2006-04-18 Mitsubishi Pharma Corporation 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same
CA2326222C (en) * 1998-04-27 2008-09-23 Fujisawa Pharmaceutical Co., Ltd. Medicinal compositions
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
GB0108498D0 (en) * 2001-04-04 2001-05-23 Novartis Ag Organic Compounds
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
JP2005230125A (ja) 2004-02-17 2005-09-02 Aruze Corp ゲーム装置及びゲームプログラム
KR100866728B1 (ko) * 2004-11-12 2008-11-03 주식회사종근당 타크로리무스를 함유하는 주사제
CN101869547B (zh) 2009-04-24 2012-02-22 张娜 一种他克莫司注射制剂
KR101230573B1 (ko) * 2010-04-21 2013-02-06 닥터후 주식회사 천년초 추출물 또는 백년초 추출물을 함유하는 천연 유화제 및 이를 포함하는 화장품 조성물, 식품 조성물 및 의약 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CH677448A5 (ja) * 1987-11-09 1991-05-31 Sandoz Ag
EP0323042A1 (en) * 1987-12-09 1989-07-05 FISONS plc Process to macrocyclic compounds
EP0356399A3 (en) * 1988-08-26 1991-03-20 Sandoz Ag Substituted 4-azatricyclo (22.3.1.04.9) octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them
GB8925797D0 (en) * 1989-11-15 1990-01-04 Fisons Plc Compositions
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506

Also Published As

Publication number Publication date
IE66592B1 (en) 1996-01-24
DE69105915D1 (de) 1995-01-26
AU655603B2 (en) 1995-01-05
US5955469A (en) 1999-09-21
EP0483842B1 (en) 1994-12-14
JPH059117A (ja) 1993-01-19
AU8692291A (en) 1992-05-07
UA43820C2 (uk) 2002-01-15
KR920009400A (ko) 1992-06-25
ES2064856T3 (es) 1995-02-01
CA2054629C (en) 2002-04-16
CA2054629A1 (en) 1992-05-03
HU343891D0 (en) 1992-01-28
CN1069194C (zh) 2001-08-08
RU2084222C1 (ru) 1997-07-20
IE913813A1 (en) 1992-05-22
DK0483842T3 (da) 1995-02-20
HUT60924A (en) 1992-11-30
PT99398B (pt) 1999-04-30
DE69105915T2 (de) 1995-05-04
HU217540B (hu) 2000-02-28
KR100206722B1 (ko) 1999-07-01
CN1061153A (zh) 1992-05-20
ATE115400T1 (de) 1994-12-15
EP0483842A1 (en) 1992-05-06
PT99398A (pt) 1992-09-30

Similar Documents

Publication Publication Date Title
PH31204A (en) Pharmaceutical composition.
DK0411153T3 (ja)
GR3032905T3 (en) Use of halogenated hydrocarbon solvents.
EP0539588A4 (ja)
ATE240734T1 (de) Zubereitung von xanthinderivaten als feste dispersion
AU7194991A (en) Macrolide pharmaceutical solutions
GR3022165T3 (en) Anti-virus agent
TW223637B (ja)
AU7415387A (en) Imidazolesulfonamide derivatives and herbicides
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
AU6117698A (en) Antiviral agents
ATE166205T1 (de) Tb-wirksame carbonsäure
AU740079C (en) Antirheumatic agents
SG52733A1 (en) Methotrexate derivative
DE69533573D1 (de) Anxiolytischer wirkstoff
IN172911B (ja)
EP0659752A4 (ja)
TH15376A (th) อนุพันธ์กรดไฮดรอกเซมิค
TH14179A (th) อนุพันธ์ของ n-(ไฮดรอกซิเอธิล) บิวเทนไดแอมีด